Moncef Slaoui to Return About $3.9 Million in Cash to GSK
Moncef Slaoui, former Operation Warp Speed chief science adviser, has agreed to return nearly $3.9 million in cash to GlaxoSmithKline (GSK), his one-time employer, following sexual harassment allegations that surfaced one year ago.
The company exercised a claw back provision to recoup the money from Slaoui, who last year was forced to step down as chairman of Galvani Bioelectronics, a company in which GSK is the majority shareholder.
At the time, GSK said it received a letter detailing the allegations and that an independent investigation substantiated the female employee’s claims. In its 2021 annual report, GSK said that Slaoui complied with its request in December.